66 results
8-K
EX-10.1
TXMD
TherapeuticsMD Inc
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
in the environment in such quantity or state that it contravenes any Environmental Law; (b) petroleum and its refined products; (c) polychlorinated biphenyls; (d) any
8-K
EX-10.1
TXMD
TherapeuticsMD Inc
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
) petroleum and its refined products; (c) polychlorinated biphenyls; (d) any substance exhibiting a hazardous waste characteristic, including, without
8-K
EX-10.1
TXMD
TherapeuticsMD Inc
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
and
which is present in the environment in such quantity or state that it contravenes any Environmental Law; (b) petroleum and its refined products; (c
8-K
EX-10.2
re0ld
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-2.1
1guv 914h
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-2.1
iryqx
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
S-3ASR
EX-1.2
hgoht3y5
4 Mar 21
Automatic shelf registration
12:00am
8-K
EX-1.1
qj4u7hz1msno9iqtl9h
16 Feb 21
Entry into a Material Definitive Agreement
8:35am
8-K
EX-1.1
nqkotez8x0hj9t jsy8
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-1.1
w5piedf5189g
13 Nov 20
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
mzxsdeg1nosabtc
29 Oct 19
Entry into a Material Definitive Agreement
8:52am
8-K
EX-1.1
marrzd3
3 Aug 18
Entry into a Material Definitive Agreement
9:28am
8-K
EX-1.1
zy5t7rwp9iip9a3
15 Jul 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
qb4ex6au93b
4 Aug 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
cp71jtij6vhfhnewh
25 Sep 13
Therapeuticsmd Announces Pricing of Offering of Common Stock
12:00am